Literature DB >> 26711143

Aspernigrins with anti-HIV-1 activities from the marine-derived fungus Aspergillus niger SCSIO Jcsw6F30.

Xuefeng Zhou1, Wei Fang2, Suiyi Tan3, Xiuping Lin1, Tianrong Xun3, Bingjie Yang4, Shuwen Liu5, Yonghong Liu6.   

Abstract

Two new 2-benzylpyridin-4-one containing metabolites, aspernigrins C (3) and D (4), together with six known compounds (1, 2, and 5-8), were isolated from the marine-derived fungus Aspergillus niger SCSIO Jcsw6F30. The structures of the new compounds were determined by NMR, MS, and optical rotation analyses. All the isolated compounds were evaluated for their inhibitory activities against infection with HIV-1 SF162 in TZM-bl cells. Malformin C (5) showed the strongest anti-HIV-1 activity with IC50 of 1.4±0.06μM (selectivity index, 11.4), meanwhile aspernigrin C (3) also exhibited potent activity with IC50 of 4.7±0.4μM (selectivity index, 7.5).
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aspergillus niger; Aspernigrins; HIV-1 SF162; Malformin C

Mesh:

Substances:

Year:  2015        PMID: 26711143     DOI: 10.1016/j.bmcl.2015.12.005

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Isobenzofuranones and Isochromenones from the Deep-Sea Derived Fungus Leptosphaeria sp. SCSIO 41005.

Authors:  Xiaowei Luo; Xiuping Lin; Limbadri Salendra; Xiaoyan Pang; Yu Dai; Bin Yang; Juan Liu; Junfeng Wang; Xuefeng Zhou; Yonghong Liu
Journal:  Mar Drugs       Date:  2017-06-29       Impact factor: 5.118

Review 2.  Safety of the fungal workhorses of industrial biotechnology: update on the mycotoxin and secondary metabolite potential of Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei.

Authors:  Jens C Frisvad; Lars L H Møller; Thomas O Larsen; Ravi Kumar; José Arnau
Journal:  Appl Microbiol Biotechnol       Date:  2018-10-06       Impact factor: 4.813

Review 3.  Novel Antiretroviral Structures from Marine Organisms.

Authors:  Karlo Wittine; Lara Saftić; Željka Peršurić; Sandra Kraljević Pavelić
Journal:  Molecules       Date:  2019-09-26       Impact factor: 4.411

Review 4.  Marine Pharmacology in 2016-2017: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2021-01-21       Impact factor: 5.118

5.  Involvement of RSK1 activation in malformin-enhanced cellular fibrinolytic activity.

Authors:  Yukio Koizumi; Kenichiro Nagai; Lina Gao; Souichi Koyota; Tomokazu Yamaguchi; Miyuki Natsui; Yumiko Imai; Keiji Hasumi; Toshihiro Sugiyama; Keiji Kuba
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

Review 6.  Antiviral potential of natural products from marine microbes.

Authors:  Mengqi Yi; Sixiao Lin; Bin Zhang; Haixiao Jin; Lijian Ding
Journal:  Eur J Med Chem       Date:  2020-08-31       Impact factor: 6.514

7.  Asperpyrone-Type Bis-Naphtho-γ-Pyrones with COX-2-Inhibitory Activities from Marine-Derived Fungus Aspergillus niger.

Authors:  Wei Fang; Xiuping Lin; Jianjiao Wang; Yonghong Liu; Huaming Tao; Xuefeng Zhou
Journal:  Molecules       Date:  2016-07-20       Impact factor: 4.411

8.  A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor.

Authors:  Suiyi Tan; Wenjuan Li; Zhaofeng Li; Yujing Li; Jiangyan Luo; Liangzhentian Yu; Jie Yang; Mengjie Qiu; Hongyan Cheng; Wei Xu; Shibo Jiang; Lu Lu; Shuwen Liu; Weifeng Ma
Journal:  Viruses       Date:  2019-09-18       Impact factor: 5.048

Review 9.  Recent Discovery of Heterocyclic Alkaloids from Marine-Derived Aspergillus Species.

Authors:  Kuo Xu; Xiao-Long Yuan; Chen Li; And Xiao-Dong Li
Journal:  Mar Drugs       Date:  2020-01-14       Impact factor: 5.118

10.  Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study.

Authors:  Mai H ElNaggar; Ghada M Abdelwahab; Omnia Kutkat; Mohamed GabAllah; Mohamed A Ali; Mohamed E A El-Metwally; Ahmed M Sayed; Usama Ramadan Abdelmohsen; Ashraf T Khalil
Journal:  Mar Drugs       Date:  2022-02-28       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.